Designing OIG-Compliant Affordability Programs

Affordability programs are critical for ensuring patient access, but they must be designed with careful attention to regulatory requirements. OIG safe harbor guidelines, fraud and abuse prevention, and compliance governance are essential considerations.

Understanding OIG Safe Harbor

The OIG safe harbor framework provides guidance on how manufacturers can support patient access without running afoul of anti-kickback statutes. Key elements include:

• Ensuring programs are available to all patients regardless of insurance status
• Limiting copay assistance to amounts that do not exceed the patient's out-of-pocket costs
• Maintaining transparent pricing and clear program terms
• Documenting compliance efforts and maintaining audit trails

Program Architecture

Effective affordability programs typically include multiple components:

Patient Assistance Programs (PAPs) provide free or discounted medications to uninsured and underinsured patients. These programs require careful eligibility determination and documentation.

Copay Assistance Programs help insured patients manage their out-of-pocket costs. These programs must be designed to complement insurance benefits, not circumvent them.

Bridge Programs provide temporary medication access while patients navigate insurance approval processes. These programs are critical for reducing time-to-therapy and improving treatment initiation rates.

Compliance Governance

Successful affordability programs require robust compliance governance. This includes:

• Regular training for field teams on program rules and compliance requirements
• Audit procedures to monitor program performance and identify compliance gaps
• Documentation and record-keeping to support compliance efforts
• Escalation procedures for handling edge cases and compliance questions

Balancing Access & Financial Viability

The goal of affordability programs is to maximize patient access while protecting the financial viability of the brand. This requires careful program design, continuous monitoring, and willingness to adjust programs based on real-world experience.

Organizations that invest in compliance and patient access will build stronger relationships with patients, healthcare providers, and payers.